The 3Ds in virus-like particle based-vaccines: “Design, Delivery and Dynamics ”

Vaccination against Allergy: A Paradigm Shift?

(2020) Martin F. Bachmann et al.   TRENDS IN MOLECULAR MEDICINE

Plague vaccine: recent progress and prospects

(2019) Wei Sun et al.   npj Vaccines

Active immunisation targeting nerve growth factor attenuates chronic pain behaviour in murine osteoarthritis

(2019) Isabell S von Loga et al.   ANNALS OF THE RHEUMATIC DISEASES

Immunization of cats to induce neutralizing antibodies against Fel d 1, the major feline allergen in human subjects

(2019) Franziska Thoms et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Correction to: Vaccination with nanoparticles combined with micro-adjuvants protects against cancer

(2019) Mona O. Mohsen et al.   Journal for ImmunoTherapy of Cancer

Mapping spheroid rotation modes in turbulent channel flow: effects of shear, turbulence and particle inertia

(2019) Lihao Zhao et al.   JOURNAL OF FLUID MECHANICS

Role of Multivalency and Antigenic Threshold in Generating Protective Antibody Responses

(2019) Mark K. Slifka et al.   Frontiers in Immunology

Targeting Mutated Plus Germline Epitopes Confers Pre-clinical Efficacy of an Instantly Formulated Cancer Nano-Vaccine

(2019) Mona O. Mohsen et al.   Frontiers in Immunology

RNA and Toll-Like Receptor 7 License the Generation of Superior Secondary Plasma Cells at Multiple Levels in a B Cell Intrinsic Fashion

(2019) Caroline C. Krueger et al.   Frontiers in Immunology

Type of RNA Packed in VLPs Impacts IgG Class Switching—Implications for an Influenza Vaccine Design

(2019) Ariane C. Gomes et al.   Vaccines

Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection

(2019) Gustavo Cabral-Miranda et al.   Vaccines

Virus‐like particles for vaccination against cancer

(2019) Mona O. Mohsen et al.   Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology

Early Transcriptional Signature in Dendritic Cells and the Induction of Protective T Cell Responses Upon Immunization With VLPs Containing TLR Ligands—A Role for CCL2

(2019) Ariane C. Gomes et al.   Frontiers in Immunology

Virus-Specific Secondary Plasma Cells Produce Elevated Levels of High-Avidity Antibodies but Are Functionally Short Lived

(2019) Caroline C. Krueger et al.   Frontiers in Immunology

Bacteriophage MS2 displays unreported capsid variability assembling T  = 4 and mixed capsids

(2019) Natàlia Martín Garrido et al.   MOLECULAR MICROBIOLOGY

Cytoplasmic glycoengineering enables biosynthesis of nanoscale glycoprotein assemblies

(2019) Hanne L. P. Tytgat et al.   Nature Communications

Interleukin 31 in insect bite hypersensitivity—Alleviating clinical symptoms by active vaccination against itch

(2019) Florian Olomski et al.   ALLERGY

Murine CD8 T‐cell functional avidity is stable in vivo but not in vitro: Independence from homologous prime/boost time interval and antigen density

(2019) Connie B. Gilfillan et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Vaccine against peanut allergy based on engineered virus-like particles displaying single major peanut allergens

(2019) Federico Storni et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Vaccination against IL-31 for the treatment of atopic dermatitis in dogs

(2018) Martin F. Bachmann et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Intranasal vaccination with M2e5x virus-like particles induces humoral and cellular immune responses conferring cross-protection against heterosubtypic influenza viruses

(2018) Young-Tae Lee et al.   PLoS One

Active vaccination against interleukin-5 as long-term treatment for insect-bite hypersensitivity in horses

(2018) Antonia Fettelschoss-Gabriel et al.   ALLERGY

Induction of Human T-cell and Cytokine Responses Following Vaccination with a Novel Influenza Vaccine

(2018) David A. G. Skibinski et al.   Scientific Reports

Delivering adjuvants and antigens in separate nanoparticles eliminates the need of physical linkage for effective vaccination

(2017) Mona O. Mohsen et al.   JOURNAL OF CONTROLLED RELEASE

Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particles

(2017) Marika Doucet et al.   PLoS One

Major findings and recent advances in virus–like particle (VLP)-based vaccines

(2017) Mona O. Mohsen et al.   SEMINARS IN IMMUNOLOGY

Immunogenicity, safety and tolerability of intradermal influenza vaccines

(2017) Ivan F. N. Hung et al.   Human Vaccines & Immunotherapeutics

Adjusted Particle Size Eliminates the Need of Linkage of Antigen and Adjuvants for Appropriated T Cell Responses in Virus-Like Particle-Based Vaccines

(2017) Ariane C. Gomes et al.   Frontiers in Immunology

Incorporation of tetanus-epitope into virus-like particles achieves vaccine responses even in older recipients in models of psoriasis, Alzheimer’s and cat allergy

(2017) Andris Zeltins et al.   npj Vaccines

Development of an Interleukin-1β Vaccine in Patients with Type 2 Diabetes

(2016) Claudia Cavelti-Weder et al.   MOLECULAR THERAPY

Polio vaccination: past, present and future

(2015) Ananda S Bandyopadhyay et al.   Future Microbiology

Dissociation of skeletal muscle for flow cytometric characterization of immune cells in macaques

(2015) Frank Liang et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Encapsidation of Host RNAs by Cucumber Necrosis Virus Coat Protein during both Agroinfiltration and Infection

(2015) Kankana Ghoshal et al.   JOURNAL OF VIROLOGY

The Interface between Hepatitis B Virus Capsid Proteins Affects Self-Assembly, Pregenomic RNA Packaging, and Reverse Transcription

(2015) Zhenning Tan et al.   JOURNAL OF VIROLOGY

In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer

(2015) P. H. Lizotte et al.   Nature Nanotechnology

The prevention and eradication of smallpox: a commentary on Sloane (1755) 'An account of inoculation'

(2015) R. A. Weiss et al.   PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES

A Novel Prime and Boost Regimen of HIV Virus-Like Particles with TLR4 Adjuvant MPLA Induces Th1 Oriented Immune Responses against HIV

(2015) Ethan Poteet et al.   PLoS One

Viral Particles Drive Rapid Differentiation of Memory B Cells into Secondary Plasma Cells Producing Increased Levels of Antibodies

(2014) F. Zabel et al.   JOURNAL OF IMMUNOLOGY

Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine: Results from a double-blinded, randomized Phase I clinical trial in healthy Asian volunteers

(2014) Jenny G.H. Low et al.   VACCINE

Preclinical efficacy and safety of an anti-IL-1β vaccine for the treatment of type 2 diabetes

(2014) Gunther Spohn et al.   Molecular Therapy-Methods & Clinical Development

Cross-talk between skeletal muscle and immune cells: muscle-derived mediators and metabolic implications

(2013) Nicolas J. Pillon et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Yeast-Expressed Bacteriophage-Like Particles for the Packaging of Nanomaterials

(2013) Janis Freivalds et al.   MOLECULAR BIOTECHNOLOGY

Mechanisms of Action of Adjuvants

(2013) Sunita Awate et al.   Frontiers in Immunology

Developments in rabies vaccines

(2012) D. J. Hicks et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8+T-cell responses in melanoma patients

(2012) Simone M. Goldinger et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Innate Immunity Mediates Follicular Transport of Particulate but Not Soluble Protein Antigen

(2012) A. Link et al.   JOURNAL OF IMMUNOLOGY

Analysis of the size of DNA packaged by the human JC virus-like particle

(2012) Chiung-Yao Fang et al.   JOURNAL OF VIROLOGICAL METHODS

Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study

(2012) Bengt Winblad et al.   LANCET NEUROLOGY

Virus like particle based strategy to elicit HIV-protective antibodies to the alpha-helic regions of gp41

(2012) C. Pastori et al.   VIROLOGY

CpG DNA as a vaccine adjuvant

(2011) Christian Bode et al.   Expert Review of Vaccines

Evidence based route of administration of vaccines

(2011) Ian F. Cook   Human vaccines & immunotherapeutics

The Second-Generation Active A  Immunotherapy CAD106 Reduces Amyloid Accumulation in APP Transgenic Mice While Minimizing Potential Side Effects

(2011) C. Wiessner et al.   JOURNAL OF NEUROSCIENCE

T Cell-dependent and -Independent IgA Responses: Role of TLR Signalling

(2010) Juliana Bessa et al.   IMMUNOLOGICAL INVESTIGATIONS

Cutting Edge: IL-21 and TLR Signaling Regulate Germinal Center Responses in a B Cell-Intrinsic Manner

(2010) J. Bessa et al.   JOURNAL OF IMMUNOLOGY

Memory and Effector CD8 T-cell Responses After Nanoparticle Vaccination of Melanoma Patients

(2010) Daniel E. Speiser et al.   JOURNAL OF IMMUNOTHERAPY

Innate signaling regulates cross-priming at the level of DC licensing and not antigen presentation

(2009) Susanne A. Keller et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Alveolar Macrophages and Lung Dendritic Cells Sense RNA and Drive Mucosal IgA Responses

(2009) J. Bessa et al.   JOURNAL OF IMMUNOLOGY

Virus-like Particle (VLP) Lymphatic Trafficking and Immune Response Generation After Immunization by Different Routes

(2009) Rafael Cubas et al.   JOURNAL OF IMMUNOTHERAPY

Assembly of mixed rod-like and spherical particles from group I and II RNA bacteriophage coat proteins

(2009) Janis Rumnieks et al.   VIROLOGY

Representation of viruses in the remediated PDB archive

(2008) Catherine L. Lawson et al.   ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY

Melanoma vaccine candidates from chimeric hepatitis B core virus-like particles carrying a tumor-associated MAGE-3 epitope

(2008) Andris Kazaks et al.   Biotechnology Journal

Nanoparticles target distinct dendritic cell populations according to their size

(2008) Vania Manolova et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study

(2008) Alain C Tissot et al.   LANCET